• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型截短种系变异增强了 作为家族性非髓样甲状腺癌的易感基因。

Novel truncating germline variant reinforces as a susceptibility gene for familial non-medullary thyroid cancer.

机构信息

Biochemistry and Molecular Genetics Department, Hospital Clinic de Barcelona, Barcelona, Spain

Biomedicina, Universitat de Barcelona Facultat de Medicina i Ciencies de la Salut, Barcelona, Spain.

出版信息

J Med Genet. 2024 Sep 24;61(10):939-942. doi: 10.1136/jmg-2024-110185.

DOI:10.1136/jmg-2024-110185
PMID:39103207
Abstract

BACKGROUND

It has long been observed that there are families in which non-medullary thyroid cancer (NMTC) occurs, but few syndromes and genes have been described to date. Proteins in the shelterin complex have been implied in cancer. Here, we have studied shelterin genes in families affected by NMTC (FNMTC).

METHODS

We performed whole-exome sequencing (WES) in 10 affected individuals from four families with at least three affected members. Polymerase chain reaction (PCR) and Sanger sequencing were performed to search for variants in the gene in 40 FNMTC families. TINF2 transcripts and loss of heterozygosity (LOH) were studied in several affected patients of one family.

RESULTS

We found the c.507G>T variant in heterozygosis in the gene in one family, co-segregating in all five affected members. This variant affects the normal splicing. LOH was not observed.

CONCLUSIONS

Our results reinforce the gene as a susceptibility cause of FNMTC suggesting the importance of location of frameshift variants in . According to our data and previous literature, pathogenic variants appear to be a significant risk factor for the development of NMTC and/or melanoma.

摘要

背景

长期以来,人们观察到有些家族会发生非髓样甲状腺癌(NMTC),但迄今为止,仅有少数综合征和基因被描述。庇护素复合物中的蛋白已被暗示与癌症有关。在这里,我们研究了受 NMTC(家族性非髓样甲状腺癌,FNMTC)影响的家族中的庇护素基因。

方法

我们对来自四个至少有三个受影响成员的家族的 10 名受影响个体进行了全外显子组测序(WES)。对 40 个 FNMTC 家族进行了 PCR 和 Sanger 测序,以搜索 基因中的变异。在一个家族的几个受影响的患者中研究了 TINF2 转录物和杂合性丢失(LOH)。

结果

我们在一个家族中发现了 基因中的杂合 c.507G>T 变异,该变异在所有五个受影响的成员中共同遗传。该变体影响正常剪接。未观察到 LOH。

结论

我们的结果强化了 基因作为 FNMTC 的易感原因,表明移码变异的位置在 中很重要。根据我们的数据和以前的文献,致病性变异似乎是 NMTC 和/或黑色素瘤发展的重要危险因素。

相似文献

1
Novel truncating germline variant reinforces as a susceptibility gene for familial non-medullary thyroid cancer.新型截短种系变异增强了 作为家族性非髓样甲状腺癌的易感基因。
J Med Genet. 2024 Sep 24;61(10):939-942. doi: 10.1136/jmg-2024-110185.
2
A Truncating Germline Mutation of in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.甲状腺癌或黑色素瘤患者种系截断突变导致端粒更长。
Thyroid. 2020 Feb;30(2):204-213. doi: 10.1089/thy.2019.0156.
3
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.家族性非髓样甲状腺癌 (FNMTC) 和遗传性非息肉病性结直肠癌 (HNPCC) 相关肿瘤的共存——一项队列研究。
Front Endocrinol (Lausanne). 2021 Jul 13;12:653401. doi: 10.3389/fendo.2021.653401. eCollection 2021.
4
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.端粒延长种系变异易患综合征型甲状腺乳头状癌亚型。
Am J Hum Genet. 2024 Jun 6;111(6):1114-1124. doi: 10.1016/j.ajhg.2024.04.006. Epub 2024 Apr 29.
5
Identification of Rare Variants Predisposing to Thyroid Cancer.鉴定甲状腺癌易感罕见变异。
Thyroid. 2019 Jul;29(7):946-955. doi: 10.1089/thy.2018.0736. Epub 2019 May 13.
6
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.全外显子组和靶向测序鉴定 MAP2K5 为家族性非髓样甲状腺癌的新易感基因。
Int J Cancer. 2019 Mar 15;144(6):1321-1330. doi: 10.1002/ijc.31825. Epub 2018 Sep 24.
7
Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).家族性非髓样甲状腺癌(FNMTC)患者中一种新型种系FOXE1变体的鉴定。
Endocrine. 2015 May;49(1):204-14. doi: 10.1007/s12020-014-0470-0. Epub 2014 Nov 9.
8
Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.家族性非髓样甲状腺癌患者中易感基因座的等位基因丢失与 BRAF 和 RAS 突变的发生。
J Surg Oncol. 2012 Jan;105(1):10-4. doi: 10.1002/jso.22064. Epub 2011 Aug 8.
9
Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.在家族性非髓样甲状腺癌的部分家族中 POT1 基因无突变。
Horm Cancer. 2020 Apr;11(2):111-116. doi: 10.1007/s12672-020-00383-5. Epub 2020 Mar 14.
10
Familial nonmedullary thyroid cancer: a case series in Iranian patients with a meta-review of case series.家族性非髓样甲状腺癌:伊朗患者病例系列及病例系列荟萃回顾
Lab Med. 2024 Jul 3;55(4):506-516. doi: 10.1093/labmed/lmad098.